230 related articles for article (PubMed ID: 31568062)
21. von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.
Hickey MM; Lam JC; Bezman NA; Rathmell WK; Simon MC
J Clin Invest; 2007 Dec; 117(12):3879-89. PubMed ID: 17992257
[TBL] [Abstract][Full Text] [Related]
22. When Biochemical Phenotype Predicts Genotype: Pheochromocytoma and Paraganglioma.
Yan Q; Bancos I; Gruber LM; Bancos C; McKenzie TJ; Babovic-Vuksanovic D; Young WF
Am J Med; 2018 May; 131(5):506-509. PubMed ID: 29391129
[No Abstract] [Full Text] [Related]
23. Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster.
Perrotta S; Nobili B; Ferraro M; Migliaccio C; Borriello A; Cucciolla V; Martinelli V; Rossi F; Punzo F; Cirillo P; Parisi G; Zappia V; Rotoli B; Della Ragione F
Blood; 2006 Jan; 107(2):514-9. PubMed ID: 16210343
[TBL] [Abstract][Full Text] [Related]
24. Genetic basis of unexplained erythrocytosis in Indian patients.
Mallik N; Sharma P; Kaur Hira J; Chhabra S; Sreedharanunni S; Kumar N; Naseem S; Sachdeva MUS; Ahluwalia J; Malhotra P; Varma N; Varma S; Das R
Eur J Haematol; 2019 Aug; 103(2):124-130. PubMed ID: 31132167
[TBL] [Abstract][Full Text] [Related]
25. Low frequency of VHL gene mutations in young individuals with polycythemia and high serum erythropoietin.
Randi ML; Murgia A; Putti MC; Martella M; Casarin A; Opocher G; Fabris F
Haematologica; 2005 May; 90(5):689-91. PubMed ID: 15921386
[TBL] [Abstract][Full Text] [Related]
26. Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia.
van Rooijen E; Voest EE; Logister I; Korving J; Schwerte T; Schulte-Merker S; Giles RH; van Eeden FJ
Blood; 2009 Jun; 113(25):6449-60. PubMed ID: 19304954
[TBL] [Abstract][Full Text] [Related]
27. Increased transferrin protects from thrombosis in Chuvash erythrocytosis.
Shah BN; Zhang X; Sergueeva AI; Miasnikova GY; Ganz T; Prchal JT; Gordeuk VR
Am J Hematol; 2023 Oct; 98(10):1532-1539. PubMed ID: 37435906
[TBL] [Abstract][Full Text] [Related]
28. Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.
Gergics P; Patocs A; Toth M; Igaz P; Szucs N; Liko I; Fazakas F; Szabo I; Kovacs B; Glaz E; Racz K
Eur J Endocrinol; 2009 Sep; 161(3):495-502. PubMed ID: 19574279
[TBL] [Abstract][Full Text] [Related]
29. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
Opocher G; Conton P; Schiavi F; Macino B; Mantero F
Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
[TBL] [Abstract][Full Text] [Related]
30. The N131S mutation in the von Hippel-Lindau gene in a Japanese family with pheochromocytoma and hemangioblastomas.
Imanaka M; Iida K; Takahashi K; Tsuji K; Nishizawa H; Fukuoka H; Takeno R; Takahashi Y; Okimura Y; Kaji H; Chihara K
Endocr J; 2006 Dec; 53(6):819-27. PubMed ID: 17001110
[TBL] [Abstract][Full Text] [Related]
31. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
[TBL] [Abstract][Full Text] [Related]
32. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Jimenez C; Cabanillas ME; Santarpia L; Jonasch E; Kyle KL; Lano EA; Matin SF; Nunez RF; Perrier ND; Phan A; Rich TA; Shah B; Williams MD; Waguespack SG
J Clin Endocrinol Metab; 2009 Feb; 94(2):386-91. PubMed ID: 19017755
[TBL] [Abstract][Full Text] [Related]
33. Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients.
Bento MC; Chang KT; Guan Y; Liu E; Caldas G; Gatti RA; Prchal JT
Haematologica; 2005 Jan; 90(1):128-9. PubMed ID: 15642680
[TBL] [Abstract][Full Text] [Related]
34. Phaeochromocytoma associated with a de novo VHL mutation as form fruste of von Hippel-Lindau disease.
Frenzel S; Apel TW; Heidemann PH; Zerres K; Neumann HP; Dörr HG
Eur J Pediatr; 2001 Jul; 160(7):421-4. PubMed ID: 11475579
[TBL] [Abstract][Full Text] [Related]
35. Familial isolated pheochromocytoma presenting a new mutation in the von Hippel-Lindau gene.
Sansó G; Rudaz MC; Levin G; Barontini M
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1107-11. PubMed ID: 15607616
[TBL] [Abstract][Full Text] [Related]
36. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway.
Yang M; Zhu M; Song K; Wuren T; Yan J; Ge RL; Ji L; Cui S
Life Sci; 2021 Feb; 266():118873. PubMed ID: 33309718
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation in the von Hippel-Lindau tumor suppressor gene identified in a Japanese family with pheochromocytoma and hepatic hemangioma.
Takahashi K; Iida K; Okimura Y; Takahashi Y; Naito J; Nishikawa S; Kadowaki S; Iguchi G; Kaji H; Chihara K
Intern Med; 2006; 45(5):265-9. PubMed ID: 16595991
[TBL] [Abstract][Full Text] [Related]
38. Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia.
Russell RC; Sufan RI; Zhou B; Heir P; Bunda S; Sybingco SS; Greer SN; Roche O; Heathcote SA; Chow VW; Boba LM; Richmond TD; Hickey MM; Barber DL; Cheresh DA; Simon MC; Irwin MS; Kim WY; Ohh M
Nat Med; 2011 Jun; 17(7):845-53. PubMed ID: 21685897
[TBL] [Abstract][Full Text] [Related]
39. Case of parotid mucoepidermoid carcinoma: Expanding the spectrum of von Hippel-Lindau-related neoplasms.
Berger MH; Kerr DA; Rangel Filho AE; Sargi ZB
Head Neck; 2017 Mar; 39(3):E51-E54. PubMed ID: 28006088
[TBL] [Abstract][Full Text] [Related]
40. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
